Literature DB >> 1584846

Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies.

X M Yang1, A L Gorman, A J Dunn, N E Goeders.   

Abstract

The effects of cocaine on defensive withdrawal behavior in rats and elevated plus-maze behavior in mice were investigated. Cocaine (20 mg/kg IP) injected daily for 7 or 14 days induced defensive withdrawal; that is, the latency to emerge from a small chamber in an open field and the mean time in the chamber were both significantly increased. Acute cocaine administration also induced defensive withdrawal, and this effect was prevented by prior treatment with chlordiazepoxide (5 mg/kg IP). Both acute and chronic cocaine treatments significantly increased plasma concentrations of corticosterone and reduced the ratios of 3,4-dihydroxyphenylacetic acid to dopamine and 5-hydroxyindoleacetic acid to serotonin in several brain regions. Further evidence for an acute anxiogenic effect of cocaine was obtained from mice studied in the elevated plus-maze. Acute cocaine administration decreased both the number of entries into and the time spent in the open arms of the maze. These results taken together strongly support an anxiogenic action of acute and chronic cocaine administration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584846     DOI: 10.1016/0091-3057(92)90386-t

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  44 in total

1.  Chronic cocaine self-administration attenuates the anxiogenic-like and stress potentiating effects of the benzodiazepine inverse agonist, FG 7142.

Authors:  R Parrish Waters; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2011-05-24       Impact factor: 3.533

2.  Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala.

Authors:  Marvin R Diaz; Ann M Chappell; Daniel T Christian; Nancy J Anderson; Brian A McCool
Journal:  Neuropsychopharmacology       Date:  2011-01-26       Impact factor: 7.853

Review 3.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Weakening of negative relative to positive associations with cocaine-paired cues contributes to cue-induced responding after drug removal.

Authors:  Zu-In Su; Gleb Kichaev; Jennifer Wenzel; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2011-10-08       Impact factor: 3.533

5.  Cocaine and Pavlovian fear conditioning: dose-effect analysis.

Authors:  Suzanne C Wood; Jonathan Fay; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

6.  On the positive and negative affective responses to cocaine and their relation to drug self-administration in rats.

Authors:  Aaron Ettenberg; Vira Fomenko; Konstantin Kaganovsky; Kerisa Shelton; Jennifer M Wenzel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-07       Impact factor: 4.530

7.  Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference.

Authors:  Gregory C Sartor; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

8.  The effects of medial prefrontal cortex infusions of cocaine in a runway model of drug self-administration: evidence of reinforcing but not anxiogenic actions.

Authors:  Daniel Guzman; Justin M Moscarello; Aaron Ettenberg
Journal:  Eur J Pharmacol       Date:  2009-01-10       Impact factor: 4.432

9.  Ethanol consumption reduces the adverse consequences of self-administered intravenous cocaine in rats.

Authors:  L A Knackstedt; A Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-25       Impact factor: 4.530

10.  Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-12-04       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.